Meet the Community – Caroline Spencer
                
                
                                    
                        
                            Community                        
                    
                             
     
            
    
    
            
                 
                
                                   LEXEO Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
                
                
                                    
                        
                            Industry News                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   Join FA Teen Hangouts on July 13, 2024!
                
                
                                    
                        
                            Ambassador                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   Meet the Community 2: A Closer Look – Marieke van Driel
                
                
                                    
                        
                            Community                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   Meet the Community – Claire Juip
                
                
                                    
                        
                            Community                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   June 2024 – Advocacy Newsletter
                
                
                                    
                        
                            Advocacy                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   2024 Cure FA Soirée Recap
                
                
                                    
                        
                            Events                        
                    
                             
     
            
    
    
            
                 
                
                                   C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data
                
                
                                    
                        
                            Partner News                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   Meet the Community – Kyle Duhon
                
                
                                    
                        
                            Community                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   Meet the Community – Hayden Clay Rogers
                
                
                                    
                        
                            Community                        
                    
                             
     
            
    
    
            
                                     
                
                
                                   Meet the Community – Anita Gracey
                
                
                                    
                        
                            Community                        
                    
                             
     
            
    
    
            
                 
                
                                   Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
                
                
                                    
                        
                            Industry News